Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs

Rating :
N/A  (View)

BSE: 531541 | NSE: Not Listed

5.63
-0.11 (-1.92%)
23-Oct-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  5.63
  •  5.63
  •  5.63
  •  5.74
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  305
  •  0.02
  •  8.30
  •  1.19

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 13.41
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 249.65
  • N/A
  • -0.14

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.95%
  • 2.90%
  • 51.02%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.13%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.11
  • -0.11
  • -0.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -9.74
  • -28.31
  • -73.41

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
103
404
287
162
Net Sales Growth
-
-74%
41%
77%
 
Cost Of Goods Sold
-
92
330
206
100
Gross Profit
-
11
73
81
62
GP Margin
-
10%
18%
28%
38%
Total Expenditure
-
104
361
240
133
Power & Fuel Cost
-
3
8
12
12
% Of Sales
-
3%
2%
4%
8%
Employee Cost
-
9
12
13
10
% Of Sales
-
9%
3%
5%
6%
Manufacturing Exp.
-
1
7
5
6
% Of Sales
-
1%
2%
2%
4%
General & Admin Exp.
-
1
2
3
3
% Of Sales
-
1%
1%
1%
2%
Selling & Distn. Exp.
-
0
0
1
1
% Of Sales
-
0%
0%
0%
1%
Miscellaneous Exp.
-
-2
0
0
0
% Of Sales
-
-2%
0%
0%
0%
EBITDA
-
-1
43
47
29
EBITDA Margin
-
-1%
11%
16%
18%
Other Income
-
0
0
2
0
Interest
-
24
18
21
13
Depreciation
-
10
10
11
6
PBT
-
-34
15
18
10
Tax
-
1
1
2
0
Tax Rate
-
-2%
8%
11%
0%
PAT
-
-35
14
15
10
PAT before Minority Interest
-
-35
14
16
10
Minority Interest
-
0
0
-1
0
PAT Margin
-
-34%
3%
5%
6%
PAT Growth
-
-349%
-7%
54%
 
EPS
-
-14.63
5.88
6.35
4.13

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
53
88
74
61
Share Capital
22
22
22
22
Total Reserves
31
65
51
39
Non-Current Liabilities
79
67
85
90
Secured Loans
33
20
37
54
Unsecured Loans
11
13
15
15
Long Term Provisions
0
0
0
0
Current Liabilities
264
256
185
98
Trade Payables
118
104
115
32
Other Current Liabilities
14
26
19
14
Short Term Borrowings
127
123
47
48
Short Term Provisions
4
3
4
5
Total Liabilities
396
412
346
250
Net Block
104
108
100
110
Gross Block
192
187
170
169
Accumulated Depreciation
89
79
70
59
Non Current Assets
106
111
114
110
Capital Work in Progress
2
3
13
0
Non Current Investment
0
0
0
0
Long Term Loans & Adv.
0
0
0
0
Other Non Current Assets
0
0
0
0
Current Assets
290
301
232
140
Current Investments
0
0
0
0
Inventories
76
59
44
49
Sundry Debtors
190
205
147
63
Cash & Bank
6
16
25
2
Other Current Assets
19
0
1
0
Short Term Loans & Adv.
5
20
15
24
Net Current Assets
26
45
47
41
Total Assets
396
412
346
250

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
7
37
64
0
PBT
-34
15
18
0
Adjustment
34
28
31
0
Changes in Working Capital
8
-5
17
0
Cash after chg. in Working capital
7
39
66
0
Interest Paid
0
0
0
0
Tax Paid
-1
-2
-2
0
Other Direct Exp. Paid
0
0
0
0
Extra & Other Items
0
0
0
0
Cash From Investing Activity
-5
-7
-14
0
Net Fixed Assets
-5
-7
-14
Net Investments
0
-1
-11
Others
0
1
11
Cash from Financing Activity
-13
-38
-27
0
Net Cash Inflow / Outflow
-11
-9
23
0
Opening Cash & Equivalents
16
25
2
0
Closing Cash & Equivalent
6
16
25
0

Financial Ratios

Standalone /

Consolidated
Description
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
24
39
33
27
ROA
-9%
4%
5%
4%
ROE
-49%
17%
23%
16%
ROCE
-4%
14%
20%
12%
Fixed Asset Turnover
0.55
2.32
1.74
1.01
Receivable days
692
155
130
135
Inventory Days
238
46
58
105
Payable days
364
106
111
80
Cash Conversion Cycle
565
95
77
160
Total Debt/Equity
3.38
2.07
1.60
2.14
Interest Cover
0
2
2
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.